Spero Therapeutics (SPRO) Current Taxes (2023 - 2026)
Spero Therapeutics' (SPRO) quarterly Current Taxes came in at $163000.0 in Q1 2026, down 6.32% YoY from $174000.0 in Q1 2025, and down 57.44% on a QoQ basis from $383000.0 in Q4 2025.
Spero Therapeutics (SPRO) Current Taxes (2023 - 2026) Analysis & Trends
Spero Therapeutics (SPRO) has 4 years of Current Taxes data on file, last reported at $163000.0 in Q1 2026.
- Quarterly Current Taxes fell 6.32% year-over-year to $163000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $163000.0 (down 6.32% YoY) and the FY2025 annual result came in at $383000.0, up 120.11% from the prior year.
- Current Taxes eased to $163000.0 in Q1 2026, from $383000.0 in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $2.2 million in Q3 2023 to a low of $97000.0 in Q3 2024.
- A 4-year average of $426272.7 and a median of $174000.0 in 2024 frame the typical range for Current Taxes.
- Annual changes were most pronounced in 2024 — Current Taxes tumbled 95.61% — and 2025, when it surged 120.11%.
- Tracing SPRO's Current Taxes over 4 years: stood at $387000.0 in 2023, then plunged by 55.04% to $174000.0 in 2024, then surged by 120.11% to $383000.0 in 2025, then sank by 57.44% to $163000.0 in 2026.
- The last three Current Taxes figures came in at $163000.0 (Q1 2026), $383000.0 (Q4 2025), and $163000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.23 Bn | 132.38 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.97 Bn | 78.97 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 59.88 Bn | 54.74 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.20 Bn | 37.11 Bn | 1.53 Bn | 76.32 Mn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.69 Bn | 10.30 Bn | 668.28 Mn | 76.36 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.16 Bn | 26.33 Bn | - | - |
| 10 | Spero Therapeutics | 71.88 Mn | 21.11 Mn | - | 163,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 163,000.00 |
| Mar 31, 2026 | 163,000.00 |
| Dec 31, 2025 | 383,000.00 |
| Sep 30, 2025 | 163,000.00 |
| Jun 30, 2025 | 163,000.00 |
| Mar 31, 2025 | 174,000.00 |
| Dec 31, 2024 | 174,000.00 |
| Sep 30, 2024 | 97,000.00 |
| Jun 30, 2024 | 387,000.00 |
| Mar 31, 2024 | 387,000.00 |
| Dec 31, 2023 | 387,000.00 |
| Sep 30, 2023 | 2.21 Mn |